| The frequency and clinical significance of intra-amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: an unexpected observation. | |
| | |
MedLine Citation:
|
PMID: 20146660 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Idiopathic vaginal bleeding, a common complication of pregnancy, increases the risk of small-for-gestational age (SGA) neonate, preeclampsia and preterm delivery and can be the only clinical manifestation of intra-amniotic infection and/or inflammation (IAI). Placenta previa is thought to be protective against ascending intrauterine infection, yet an excess of histologic chorioamnionitis has been reported in this condition. The aim of this study was to determine the frequency and clinical significance of IAI in women with placenta previa and vaginal bleeding in the absence of preterm labor. STUDY DESIGN: A retrospective cohort study including 35 women with placenta previa and vaginal bleeding <37 weeks of gestation who underwent amniocentesis was undertaken. Patients with multiple gestations were excluded. Intra-amniotic infection was defined as a positive culture for microorganisms, and intra-amniotic inflammation as an elevated amniotic fluid interleukin (IL)-6 concentration. IL-6 concentrations were determined by ELISA in 28 amniotic fluid samples available. Non-parametric statistics were used for analysis. RESULTS: 1) The prevalence of intra-amniotic infection was 5.7% (2/35), and that of IAI was 17.9% (5/28); 2) the gestational age at delivery was lower in patients with IAI than in those without IAI [29.4 weeks, interquartile range (IQR): 23.1-34.7 vs. 35.4 weeks, IQR: 33.9-36.9; P=0.028]; and 3) patients with placenta previa and IAI had a higher rate of delivery within 48 h (80% (4/5) vs. 19% (4/21); P=0.008) than those without IAI. CONCLUSIONS: Patients with placenta previa presenting with vaginal bleeding have intra-amniotic infection in 5.7% of the cases, and IAI in 17.9%. IAI in patients with placenta previa and vaginal bleeding is a risk factor for preterm delivery within 48 h. |
| | |
Authors:
|
Ichchha Madan; Roberto Romero; Juan Pedro Kusanovic; Pooja Mittal; Tinnakorn Chaiworapongsa; Zhong Dong; Shali Mazaki-Tovi; Edi Vaisbuch; Zeynep Alpay Savasan; Lami Yeo; Chong Jai Kim; Sonia S Hassan |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Intramural |
Journal Detail:
|
Title: Journal of perinatal medicine Volume: 38 ISSN: 1619-3997 ISO Abbreviation: J Perinat Med Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-06 Completed Date: 2010-06-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0361031 Medline TA: J Perinat Med Country: Germany |
Other Details:
|
Languages: eng Pagination: 275-9 Citation Subset: IM |
Affiliation:
|
Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, Maryland and Detroit, MI 48201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Amniocentesis Amniotic Fluid / chemistry Bacterial Infections / epidemiology Chorioamnionitis / epidemiology*, microbiology*, physiopathology Cohort Studies Female Gestational Age Humans Interleukin-6 / analysis Placenta Previa / physiopathology* Pregnancy Pregnancy Outcome / epidemiology* Premature Birth / epidemiology Retrospective Studies Risk Factors Uterine Hemorrhage / complications* |
| Chemical | |
Reg. No./Substance:
|
0/Interleukin-6 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gest...
Next Document: Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartment...